Lay campaigners for prostate screening are funded by industry

BMJ 2003; 326 doi: http://dx.doi.org/10.1136/bmj.326.7391.680 (Published 29 March 2003)
Cite this as: BMJ 2003;326:680.1

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jeanne Lenzer
  1. New York

    A lay men's group which campaigns for men to take the prostate specific antigen screening test for prostate cancer gets 95% of its funding from the pharmaceutical industry, its chief execu-tive officer admitted last week.

    The group, called Us Too! International, also led the attack on two doctors who wrote articles in the San Francisco Chronicle (2002 Jan 18;sect A:29) and the BMJ (2002;324:431) arguing that routine screening for prostate cancer was not supported by the evidence.

    Us Too! International claims to be the world's largest “grassroots, independent, patient-focused charitable organisation” and has 380 chapters in nine countries, including the United States, Canada, Australia, and the United Kingdom. The group emphasises its independence, saying …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL